47–49). The six μ4-SiPr− ligands are anchored on the quadrilateral surface of Ag(I)12 with Ag−S bond lengths in the range of 2.44(4)–2.50(4) Å, and the CF3COO− ligands on the edges in μ2−η1, η1 coordination mode (Ag−O bond lengths: 2.29(2)–2.44(4)...
Claims: What is claimed is: 1. A method for video decoding in a decoder, comprising: determining whether a current block in a current picture of a coded video sequence is a small block based on a block size threshold; constructing a motion vector predictor list for the current block based...
TFF3 has been identified as a novel biomarker to distinguish between lung adenocarcinoma (ADC) and lung squamous-cell carcinoma (SCC). Herein, we determined the oncogenic functions of TFF3 and demonstrated the potential of pharmacological inhibition of TFF3 in lung ADC using a novel small-molecule ...
The ethical approval of this study was obtained from the Ethics Committee of the Qingdao University Medical College Affiliated Yantai Yuhuangding Hospital (ID: 2022-34). Inormed consent was obtained form each patient before this study. Consent for publication Not applicable....
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. The original online version of this article was revised: There was an error in the name of Kenneth J. O’Byrne Supplementary information Supplementary Tables and Figur...
Emotional distress (ED), commonly characterized by symptoms of depression and/or anxiety, is prevalent in patients with cancer. Preclinical studies suggest that ED can impair antitumor immune responses, but few clinical studies have explored its relation
Publisher's note:Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Electronic supplementary material Supplementary Information Peer Review File Rights and permissions Open AccessThis article is licensed under a Creative Commons Attribution 4.0 ...
Cancers harboring mutations in the Kirsten rat sarcoma homolog (KRAS) gene have been associated with poor prognosis and lack of targeted therapies. KRAS mutations occur in approximately one in four patients diagnosed with non-small cell lung cancer (NSCL
Keywords: Neoadjuvant immunotherapy; non-small-cell lung cancer; pathologic complete response Received: 27 July 2022 Accepted: 25 August 2022 Published: 29 August 2022 Publisher's Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affil- iations. ...